XCRT Stock Chart & Stats
$0.01
<$0.01(15.45%)
At close: 4:00 PM EDT
$0.01
<$0.01(15.45%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.02
Previous CloseN/A
Volume80.00K
Average Volume (3M)70.29K
Market Cap
$5.39M
Enterprise Value$5.42M
Total Cash (Recent Filing)$328.93K
Total Debt (Recent Filing)$1.85M
Price to Earnings (P/E)―
Beta0.70
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding434,446,080
10 Day Avg. Volume21,244
30 Day Avg. Volume70,290
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)-1.85
Price to Sales (P/S)0.00
P/FCF Ratio-10.03
Enterprise Value/Market Cap1.01
Enterprise Value/Revenue-8.38
Enterprise Value/Gross Profit-16.35
Enterprise Value/Ebitda-46.76
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
XCRT FAQ
What was Xcelerate’s price range in the past 12 months?
Xcelerate lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is Xcelerate’s market cap?
Xcelerate’s market cap is $5.39M.
When is Xcelerate’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Xcelerate’s earnings last quarter?
Currently, no data Available
Is Xcelerate overvalued?
According to Wall Street analysts Xcelerate’s price is currently Overvalued.
Does Xcelerate pay dividends?
Xcelerate does not currently pay dividends.
What is Xcelerate’s EPS estimate?
Xcelerate’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Xcelerate have?
Xcelerate has 434,446,080 shares outstanding.
What happened to Xcelerate’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Xcelerate?
Currently, no hedge funds are holding shares in XCRT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Xcelerate
Xcelerate Inc. specializes in sourcing and integrating engineering expertise and patents, which it then applies to nascent medical technology ventures. The firm's offerings are subsequently deployed within regulated clinical settings for rigorous evaluation, validation, and real-world implementation. Beyond this, the company oversees a comprehensive, full-spectrum approach to medical technology creation and deployment. Established in 1996, the Mauldin, South Carolina-based entity was previously known as Union Dental Holdings, Inc. before rebranding as Xcelerate Inc.
Technical Analysis
American Shared Hospital Services
―
Concord Medical Services
―
Joint
―
Cryo-Cell International
―
P3 Health Partners
―